Filing Details
- Accession Number:
- 0001209191-23-049133
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-12 18:23:25
- Reporting Period:
- 2023-09-11
- Accepted Time:
- 2023-09-12 18:23:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1759425 | Mirum Pharmaceuticals Inc. | MIRM | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1197350 | Eric Bjerkholt | C/O Mirum Pharmaceuticals, Inc. 950 Tower Lane, Suite 1050 Foster City CA 94404 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-09-11 | 10,000 | $29.65 | 10,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Acquisiton | 2023-09-11 | 110,000 | $0.00 | 110,000 | $30.43 |
Common Stock | Restricted Stock Units | Acquisiton | 2023-09-11 | 55,000 | $0.00 | 55,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
110,000 | 2033-09-10 | No | 4 | A | Direct | |
55,000 | No | 4 | A | Direct |
Footnotes
- The price reported on this Form 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $29.61 to $29.65, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth herein.
- 1/4th of the shares subject to the Option will vest one year after September 11, 2023 (the "Vesting Commencement Date") and the balance of the shares will vest in a series of 36 successive equal monthly installments measured from the first anniversary of the VestingCommencement Date.
- Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- The restricted stock units vest in a series of three successive equal annual installments beginning on the one year anniversary of September 11, 2023.